Author

Felicia Ko

Northwestern UniversityORCID 0009-0008-2679-3578Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Alana G. CaldwelliD· 1 shared Ananya A. BasuiD· 1 shared Assa MagassaiD· 1 shared Chenlu ZhangiD· 1 shared Isabella A. RihaiD· 1 shared Miguel A. Lorenzo CamposiD· 1 shared Xiaoyu ZhangiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Alana G. CaldwellORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BiochemistryNature Chemical BiologyPeer-reviewedJul 4, 2024

A CRISPR activation screen identifies FBXO22 as an E3 ligase supporting targeted protein degradation

Ananya A. Basu, Chenlu Zhang, Isabella A. Riha…·Xiaoyu Zhang

This study identifies FBXO22 as an E3 ligase that supports ligand-induced protein degradation through PROTACs, expanding the toolkit for targeted protein degradation.

53 citationstop 2%

humangenetic perturbation / CRISPR

𝕏 PostBluesky